Talk about bad blood. Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Human immunodeficiency virus (HIV) is a viral infection that attacks our immune systems. Infection enters the body by contact ...
Korle Klottey Municipal Assembly, has urged Ghanaians to make Human Immunodeficiency Virus (HIV) testing a regular part of ...
The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the ...
Lenacapavir is not a vaccine. It’s a long-acting retroviral drug that prevents HIV infection by blocking the virus from replicating in the body, rather than stimulating the immune system like a ...
According to a Yolo County press release, services available to eligible individuals include payment for PrEP and/or PEP medication, HIV and sexually transmitted infection (STI) testing, STI ...
Merck & Co has presented additional data from Phase III studies of the investigational, once-daily, oral, two-drug regimen of ...